Cellular senescence as a possible mechanism for halting progression of keloid lesions
CrossRef Epicardial adipose tissue: an overtly concealed contributor to cardiovascular events in chronic kidney disease patients Liqin Cui, Min Yang Lipids in Health and Disease.2025;[Epub] CrossRef Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials Jafar Karami, Bahman Razi, Danyal Imani, Saeed Aslani, Mahdi Pakjoo, Mahdieh Fasihi, Keyhan Mohammadi, Amirhossein Sahebkar Current Pharmaceutical Design.2024
Tonev DG, Momchilova AB
doi: 10.3389/fphar.2024.1431391 Received 16 May 2024 Accepted 27 September 2024 Published 14 October 2024 Volume 15 - 2024 Edited by Nokwanda Makunga, Stellenbosch University, South Africa Reviewed by Mallikarjuna Korivi, Zhejiang Normal University, China Shifen Dong, Beijing University of Chinese Medicine, China Updates Copyright 2024 Chen, Deng, Deng, Li, Fan, Yang, Han, Xu and Chen
Cagrilintide Overview Cagrilintide is a synthetic, long-acting analog of the naturally occurring peptide amylin
You feel low energy or mentally sluggish